Boston Scientific agreed to acquire Remon Medical Technologies, an Israeli maker of wireless technology for communicating with implanted medical devices. The companies didn't disclose financial terms; their release is here.
Founded in 1997, Remon struck a co-development deal with Guidant in 2004. Boston Scientific acquired Guidant last year.
From the Boston Scientific press release:
"Remon Medical Technologies brings to Boston Scientific innovative sensor and wireless communication technology to Boston Scientific, which complements our Cardiac Rhythm Management product line," said Fred Colen, Executive Vice President, Operations and Technology, CRM, and Chief Technology Officer. "This acquisition reflects our commitment to being a leader in the CRM market through the introduction of innovative products and services for the benefit of physicians and their patients." "We've spent the last several years developing smart, miniature implants designed to enable physicians to assess and treat a variety of medical conditions in a non-invasive manner," said Hezi Himelfarb, Remon Medical Technologies, Inc.'s Chief Executive Officer. "The acquisition by Boston Scientific will position Remon as a recognized leader in intra-body wireless communication and help realize the potential of our technology, once integrated into the portfolio of Boston Scientific products."